Literature DB >> 12796827

Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis.

Gerald Niederwieser1, Wolfgang Buchinger, Raphael M Bonelli, Andrea Berghold, Franz Reisecker, Peter Költringer, Juan J Archelos.   

Abstract

Since multiple sclerosis (MS) and autoimmune thyroiditis (AIT) are presumed to be of autoimmune origin the correlation of these two diseases is of special interest. The aim of this study was to determine whether there are differences in the prevalence of thyroid disease with special emphasis on AIT compared with MS and normal subjects and whether the presence of thyroid disease correlates with disability, disease course, age, and disease duration. 353 consecutive patients with clinically definite MS, without interferon-beta treatment and 308 patients with low back pain or headache were extensively examined for the presence of non-immune or autoimmune thyroid disease. We found a significantly higher prevalence of AIT in male MS patients (9.4 %) than in male controls (1.9 %; p = 0.03). The prevalence of AIT in female MS patients (8.7 %) did not differ from female controls (9.2 %). Hypothyroidism, caused by AIT in almost all cases, showed a tendency to be more severe and more often present in patients with MS. There was no association between relapsing-remitting and secondary progressive disease course of MS and the prevalence of AIT. MS patients with AIT were significantly older but did not differ in disease duration and expanded disability status scale (EDSS). Further studies are warranted, to see if there is a difference in sex-hormone levels between MS patients with and without AIT and healthy controls. Longitudinal studies comparing MS patients with or without AIT could show whether there is an influence of AIT on the disease course or progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796827     DOI: 10.1007/s00415-003-1053-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Multiple sclerosis and autoimmune diseases: epidemiology and HLA-DR association in North-east Italy.

Authors:  Alice Laroni; Massimiliano Calabrese; Paola Perini; Maria Paola Albergoni; Federica Ranzato; Michela Tiberio; Leontino Battistin; Paolo Gallo
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

2.  Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b.

Authors:  Andreas Bitsch; Alexander Dressel; Kathrin Meier; Timon Bogumil; Florian Deisenhammer; Hayrettin Tumani; Bernd Kitze; Sigrid Poser; Frank Weber
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

Review 3.  [Autoimmune functional disorders of the thyroid during interferon-beta-1b treatment in patients with multiple sclerosis. Case report and literature review].

Authors:  C Lange-Asschenfeldt; S Boor; G J Kahaly; F Thömke
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

Review 4.  Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.

Authors:  Ruth Dobson; Gavin Giovannoni
Journal:  J Neurol       Date:  2013-01-12       Impact factor: 4.849

5.  Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity.

Authors:  Anna Lonyai; Shohta Kodama; Douglas Burger; Denise L Faustman
Journal:  Immunol Cell Biol       Date:  2008-02-26       Impact factor: 5.126

6.  Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort.

Authors:  J S Sloka; Pryse-W E M Phillips; M Stefanelli; C Joyce
Journal:  J Autoimmune Dis       Date:  2005-11-09

7.  Immunogenetics of Hashimoto's thyroiditis.

Authors:  Dimitry A Chistiakov
Journal:  J Autoimmune Dis       Date:  2005-03-11

Review 8.  A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Olaf Stuve; Per S Sorensen; Gary Cutter; Stephen C Reingold; Maria Trojano
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

Review 9.  Alemtuzumab in the treatment of multiple sclerosis.

Authors:  Oscar Fernandez
Journal:  J Inflamm Res       Date:  2014-02-12

Review 10.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.